Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Elle medical & pharmaceutical consulting AB
AB
Active
Org 5591766141
Spångavägen 352, 163 55
Spånga
Medical specialists activities
· NACE 8622
Est. 2018
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Elle medical & pharmaceutical consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2020
1M
2021
0M
2022
2M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
500
760
345
1 716
263
Staff expenses
—
—
−76
−1 027
−121
EBITDA
151
399
134
379
61
Depreciation & amort.
−0
−0
—
−2
−29
EBIT
151
399
134
377
32
Net financials
—
—
−0
1
1
Profit before tax
150
400
134
378
33
Tax
−32
−83
−28
−78
−7
Net profit
118
317
106
300
26
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
261
480
363
596
209
Equity
169
367
173
354
115
Long-term debt
0
0
—
—
—
Short-term debt
92
112
190
242
94
Total debt
92
112
190
242
94
Financial ratios
5-year trend
EBITDA margin
23.3%
This company
15.8%
Market median
+47% vs market
2020
2024
Equity ratio
54.9%
This company
38.2%
Market median
+44% vs market
2020
2024
Return on equity
22.9%
This company
18.4%
Market median
+24% vs market
2020
2024
Net profit margin
10.0%
This company
8.1%
Market median
+23% vs market
2020
2024
Asset turnover
1.26×
This company
1.12×
Market median
+12% vs market
2020
2024
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Elle medical & pharmaceutical consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
